BVT Aktienanleihe AMD 27.06.2025/ DE000VD3BN04 /
2025-04-30 4:55:18 PM | Chg.-1.440 | Bid6:56:33 PM | Ask6:56:33 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
54.970EUR | -2.55% | 55.510 Bid Size: 500,000 |
55.620 Ask Size: 500,000 |
Advanced Micro Devic... | 180.00 USD | 2025-06-27 | Call |
GlobeNewswire
2:00 PM
Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academ...
GlobeNewswire
12:55 PM
YieldMax™ ETFs Announces Distributions on CONY (102.91%), FIAT (100.78%), CVNY (86.83%), ULTY (81.75...
GlobeNewswire
04-29
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmolog...
GlobeNewswire
04-29
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
04-28
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy...
GlobeNewswire
04-24
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision a...
GlobeNewswire
04-18
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License A...
GlobeNewswire
04-17
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment ...
GlobeNewswire
04-15
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
GlobeNewswire
04-15
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pip...